Übersicht			Auf mobile öffnen

Lieferstatus:	Auf Bestellung (Lieferzeit unbekannt)
Veröffentlichung:	Dezember 2018
Genre:	Schulbücher
	B / Epidemiology & medical statistics / Industrial chemistry & chemical engineering / Management / Management & management techniques / Mathematics and Statistics / Pharmaceutical Sciences/Technology / Pharmaceutical technology / Pharmaceutics / Statistics / Statistics for Life Sciences, Medicine, Health Sciences / Statistics in Life Sciences, Medicine, Health Sciences mehr...
ISBN:	9789811350740
EAN-Code:	9789811350740
Verlag:	Springer EN
Einband:	Kartoniert
Sprache:	English
Serie:	ICSA Book Series in Statistics
Dimensionen:	H 235 mm / B 155 mm / D
Gewicht:	403 gr
Seiten:	241
Illustration:	XVII, 241 p. 25 illus., 17 illus. in color., schwarz-weiss Illustrationen, farbige Illustrationen
Zus. Info:	EUDR exemption - product or manufacturing materials placed on the market prior to 31.12.2025.
Bewertung:	Titel bewerten / Meinung schreiben

Inhalt:

This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them.